Favorable prognosis of PHGDH-high tumors was further validated in 42 independent IDH wild-type GBM tumors assessed by immunohistochemistry on a tumor tissue microarray (SMC-TMA) using an anti-PHGDH antibody (Fig. 4f). Here, IDH1 is linked to neoplasm.